Provided by Tiger Trade Technology Pte. Ltd.

CareDx

67.15
+0.92001.39%
Post-market: 70.163.01+4.48%19:49 EDT
Volume:1.59M
Turnover:106.70M
Market Cap:3.47B
PE:31.67
High:69.80
Open:66.33
Low:65.88
Close:66.23
52wk High:69.80
52wk Low:13.95
Shares:51.73M
Float Shares:48.55M
Volume Ratio:1.00
T/O Rate:3.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.12
EPS(LYR):-0.4007
ROE:29.49%
ROA:-0.25%
PB:8.16
PE(LYR):-167.57

Loading ...

Caredx is Maintained at Buy by BTIG

Dow Jones
·
Jul 17

CareDx price target raised to $45 from $28 at BTIG

TIPRANKS
·
Jul 17

Matt Larew Reiterates Hold on CareDx as Favorable MolDX Coverage Decision Removes Key Reimbursement Overhang but Valuation Now Seen as Fair

TIPRANKS
·
Jul 16

Caredx Says Final Medicare LCD Maintains Coverage for Transplant Rejection Surveillance Tests

Reuters
·
Jul 16

Press Release: Caredx to Report Second Quarter 2026 Financial Results on July 30, 2026

Dow Jones
·
Jul 16

Caredx Sets Webcast to Discuss Second-quarter 2026 Results After Market Close

Reuters
·
Jul 16

Caredx - Finalizes Medicare Local Coverage Determination for Solid Organ Transplant Molecular Testing

THOMSON REUTERS
·
Jul 16

Caredx - Final Lcd Published July 16, 2026; Effective August 30, 2026

THOMSON REUTERS
·
Jul 16

Caredx - Final Policy Affirms Coverage for Caredx Kidney, Heart, and Lung Transplant Surveillance

THOMSON REUTERS
·
Jul 16

CareDx Refocuses Portfolio With Naveris Oncology Acquisition

TIPRANKS
·
Jul 08

Caredx Completes Sale of Lab Products Unit to Eurobio Scientific for $171.2 Million Cash

Reuters
·
Jul 08

CareDx Closes Naveris Acquisition

MT Newswires Live
·
Jul 02

Caredx Completes Acquisition of Naveris, Extending Leadership into High-growth Specialty Oncology

THOMSON REUTERS
·
Jul 02

Caredx CEO John Walter Hanna Jr Disposes of USD 1.17 Million in Common Shares

Reuters
·
Jul 01

Caredx Completes Sale of Lab Products Unit to Eurobio Scientific for $171.2 Million Cash

Reuters
·
Jul 01

Caredx Announces Completion of Sale of Lab Products Business to Eurobio Scientific

THOMSON REUTERS
·
Jul 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: CareDx (CDNA) and Medtronic (MDT)

TIPRANKS
·
Jun 25

CareDx (CDNA) Stock Could Be 1.5% Overvalued After AlloSure Study Buzz

Simply Wall St.
·
Jun 22

How New AlloSure Kidney Prognostic Evidence At CareDx (CDNA) Has Changed Its Investment Story

Simply Wall St.
·
Jun 19

CareDx says study links early AlloSure elevation after kidney transplant to higher 3-year graft loss risk

Reuters
·
Jun 18